Ben Williams Email & Phone Number

Boston, Ma, Us

Portland, Or, Us

Keliomics is pioneering a groundbreaking platform in organ-scale biology that maintains the complete composition, structure, and functionality of primary human tissues. Our inaugural product lines include 1) ex vivo adipose tissues, encompassing lean versus obese, subcutaneous, visceral, and peri-organ depots; and 2) ex vivo tumors (EVTs) that significantly surpass existing technologies by cultivating tumors within donated human tissues, such as "breast cancer in human breast tissue." These EVTs exhibit essential clinical features, including T1-T4 tumor stages, adjuvant versus neoadjuvant conditions, obesity and menopausal statuses, as well as patient-specific treatment response. This innovative technology facilitates the generation of human-relevant data prior to clinical trials, helping drug developers select assets for clinical advancement. Keliomics supports preclinical development at premier cancer research institutions, including Duke, UT Southwestern, UC Berkeley, Tulane, LSU, and Legacy Health.

Berkeley, Ca, Us

Clinical-stage oncology company developing non-invasive sonodynamic therapy (SDT). Positive proof-of-concept in 40 brain tumor patients. Over $60MM in non-dilutive funding to develop SDT to treat both solid and liquid tumors.

Syracuse, New York, Us

Two-sided marketplace connecting therapeutics companies with potential acquirers, licensees and co-development partners.

I work with startups and venture funds. I've helped both bootstrapped and venture-backed startups set strategy and operating practices, raise money, and drive product engagement and revenue. I've also helped venture funds evaluate investment candidates and exits.

Princeton, Nj, Us

4M Therapeutics Inc. (4MTx) develops therapies for central nervous system (CNS) disorders with blockbuster potential. We focus on targets implicated in a wide array of disorders and indications, and use unique insights from our living human brain cell platform (developed through a collaborative effort between Harvard, MIT, and the University of Washington) to identify and design more effective and safer therapeutics. We then work to reduce cost and time to market by obtaining initial regulatory approvals for the treatment of symptoms related to behavior, mood, and cognition. We have raised $5 million to date with all founders and board members participating.The safety and efficacy of our lead compound, 4MT2001, are supported by in-human safety assessments and genetic target validation conducted by external researchers, complemented by our extensive in vitro and in vivo studies, showcasing its potential as a best-in-class treatment for bipolar disorder (BPD). BPD is a lifelong condition that usually begins in the late teens to early 20s and affects 7 million people in the U.S. alone. The FDA has provided feedback on our program, positioning us to initiate Phase 1 clinical trials in early 2025. Additionally, our pipeline includes potential breakthrough treatments for Alzheimer’s disease (AD), Parkinson’s disease (PD), and other CNS disorders.4MTx is led by CEO Pablo Lapuerta, who has developed and launched multiple therapies. His instrumental role in pioneering the first targeted CNS kinase inhibitor into clinical trials proved vital for its proof-of-concept data. Board Chair Don Hayden, former President of Global Pharmaceuticals at Bristol Myers-Squibb, led the development and commercialization of the CNS blockbuster Abilify, with peak annual sales exceeding $6B. Board member Dr. Lawrence Goldstein, a co-founder of publicly-traded Cytokinetics, is professor emeritus at UC San Diego.

Indianapolis, In, Us

We bring together biopharma industry experts to help investors and biopharma BD&L portfolio and clinical teams make better drug development decisions.

Cellgen helps the clinical trial industry harmonize its data across disparate systems and organizations. We’re like MuleSoft for clinical trials. We’re building Cellgen to bring new drugs and devices to market faster, cheaper, and safer. Our blockchain-enabled middleware will provide a single source of truth for trial data consensus, provenance, and immutability while also enabling secure transactions across the clinical trials ecosystem. The former Global Director of Next Generation Clinical Trials at Pfizer is our product lead.

Firecracker is an adaptive learning platform. The company was acquired by Wolters Kluwer (Euronext: WKL) in March 2018. Prior to our acquisition, Firecracker was focused on serving medical students, medical professionals, and their institutions (e.g. schools, hospitals). At that time, 1 out of every 2 US medical students had used Firecracker at some point during medical school and they collectively answered 10M questions/month on our platform. We had over 25 medical school partners. We had just started expanding into Residency and CME with the help of partners such as Boston Children’s Hospital, Stanford School of Medicine, and the American Board of Wound Management.

Co-founded one of the first health-focused social networks with a Co-founder of Facebook. Raised $1.3M for its development and grew the user base to over 30,000 patients and caregivers. Presented at national events including the Disease Management Colloquium (2008), Summit on Behavioral Telehealth (2008), and NASDQ HealthCare Industry Forum (2007). Firefly Health was acquired by Anideo LLC and is now Careplace (www.careplace.com).

Strategic advisor to leading medical staffing agency in the NY/NJ area with $6m+ in revenue. Assisted negotiation of largest M&A deal in company’s history, drafted RFPs for clients, advised branding/marketing effort.

Philadelphia, Pa, Us

FIMRC provides free health care to millions of underprivileged children worldwide and coordinates clinical rotation and volunteer efforts for over 700 healthcare professionals and students annually.

Philadelphia, Pa, Us

Led strategic planning, organizational development, and global operations in 5 countries. The primary recommendation of the strategic plan was to focus on growing the volunteer and international clinical rotation program -- now the largest contributor to FIMRC's multimillion-dollar operating budget.

New York, New York, Us

Promoted in Dec. 2003 from Intern to Administrative Resident – a management-training program for recent MBA/MPH graduates. Core departmental/functional rotations: Strategic Planning, Network Development, Regulatory Affairs, Performance Improvement, Quality Improvement & Patient Safety, Information Services. Certified by General Electric as a Six Sigma Green Belt, Work-Out, and CAP (Change Acceleration Process) professional. Six Sigma project: "Intra-hospital patient transport turn-around time."Member of a small, multidisciplinary team that launched BIS (Business Intelligence System), a web-based data analysis/mining and reporting tool that queries clinical and financial databases across the enterprise. Secured speaking opportunity for Emme Deland (SVP of Strategy) at the 2004 Quality Colloquium and co-presented a session on Six Sigma at the 2004 and 2005 Quality Colloquium.

As a full-time student, raised over $40,000 in grant funding, implemented advertising sales and paid-subscription revenue models, and negotiated partnerships with leading healthcare industry event planning organizations. Represented HHPR at numerous national conferences (e.g. Pharma Congress, World Congress) by introducing subjects and speakers to hundreds of C-level executives. I also interviewing world-renowned health researchers and policy-makers. Previously Managing Editor (2001-2002) and Associate Editor (2000-2001). Select Publications: B.C. Williams. 2004. Interview with Mark McClellan, FDA Commissioner. Harvard Health Policy Review 5(1): 65-72.B.C. Williams. 2003. Interview with Walter C. Willett, Chair of the Department of Nutrition, Harvard School of Public Health. Harvard Health Policy Review 4(2): 7-12.B.C. Williams. 2003. Interview with David Byrne, European Union Commissioner for Health and Consumer Protection. Harvard Health Policy Review 4(1): 17-21.

Watertown, Ma, Us

Researched consumer adoption and comprehension of comparative healthcare performance/quality data and recommended implementation strategy and user-interface options to Executive Director and other senior management.

Cambridge, Massachusetts, Us

TA for undergraduate course "The Quality of Healthcare in America" taught by Harvard Medical School professors Don Berwick, Warner Slack, and Howard Hiatt. Assisted syllabus development, course administration, and student learning and exam preparation (held office hours and led ad hoc sections).

Boston, Ma, Us

Investigated age-specific mechanisms of hypoxic/ischemic perinatal brain injury and potential drug therapies while mastering various protein assays and neonatal rodent surgery techniques.Related Abstract: Deng, W., B.C. Williams, and F. Jensen. 2003. Down-regulation of Metabotropic Glutamate Receptors in Oligodendrocyte Lineage Cells. Abstract displayed at the Harvard-MIT Conference on Neuroscience. Boston, MA.

Rahway, New Jersey, Us

Proposed a strategic plan to encourage Taiwanese Pharmaceutical Industry adoption and adherence to the IFPMA Code of Ethical Marketing Practices. Also developed nationwide patient education programs for Type-II Diabetes, Chronic Heart Disease, and Asthma. Participated in drug formulary negotiations with providers and shadowed pharmaceutical sales representatives.

Us

Trained under former Chinese Taipei National Football Team Head Coach (Chiang Mu-tsai) with Tatung F.C. (大同足球隊). The team was mostly comprised of current and former Chinese Taipei National Football Team members and finished second place (Runners-up) during the 1999/2000 season of the National Men's First Division Football League (Taiwan's professional soccer league). Also trained with the full National Team during their preparations for the AFC Asian Cup.

Carlsbad, Ca, Us

Shadowed and assisted physicians and other staff in the Physical Rehabilitation department. Assisted patients during rehabilitation exercises and collaborated with staff members to develop individualized strength, range-of-motion, and nutritional plans for patients recovering from chemotherapy, mastectomy, radical prostatectomy, etc.

Played forward (striker) for Jun Li Construction F.C., a member of the National First Division Football League (Taiwan's professional soccer league).

Park City, Utah, Us

Supervised campers, performed demonstrations with professional skateboarders, washed dishes as member of dining staff. Sponsors included Jimi Skate Shop (Taiwan), Nestle (Taiwan), and BFD Skate Shop (Hong Kong)

A.B., Biology, Health Policy

Certificate, Mandarin Chinese

High School Diploma